ONCOZ — Oncozenge AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK76.26m
- SEK74.71m
Annual balance sheet for Oncozenge AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | PRESS | ARS | ARS | ARS |
| Standards: | SAS | — | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 10 | 51.2 | 29.1 | 12.6 | 3.86 |
| Net Total Receivables | 5.51 | 0.915 | 0.19 | 0.22 | 0.519 |
| Prepaid Expenses | |||||
| Total Current Assets | 15.5 | 52.1 | 30 | 13.5 | 4.58 |
| Net Property, Plant And Equipment | 0 | — | — | — | — |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 38.3 | 85.2 | 36.9 | 20.3 | 11.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9.01 | 4.9 | 2.92 | 1.7 | 1.48 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 9.01 | 4.9 | 2.92 | 1.7 | 1.48 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 29.3 | 80.3 | 34 | 18.6 | 9.95 |
| Total Liabilities & Shareholders' Equity | 38.3 | 85.2 | 36.9 | 20.3 | 11.4 |
| Total Common Shares Outstanding |